Sort
23,748 grants matching “melanoma”
Confocal line-scanning versus point-scanning for imaging human skin in vivo
$488,823Milind Rajadhyaksha · Sloan-Kettering Inst Can Research · R01 · FY2008 · EB
Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer
$488,718Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$488,591Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Neuronal and glial interactions of neuropathic pain
$488,534Ru-Rong Ji · Duke University · R01 · FY2017 · DE
Neuronal and glial interactions of neuropathic pain
$488,534Thomas Buchheit · Duke University · R01 · FY2021 · DE
Neuronal and glial interactions of neuropathic pain
$488,534Thomas Buchheit · Duke University · R01 · FY2020 · DE
Neuronal and glial interactions of neuropathic pain
$488,534William Maixner · Duke University · R01 · FY2019 · DE
Neuronal and glial interactions of neuropathic pain
$488,534Ru-Rong Ji · Duke University · R01 · FY2018 · DE
PD-1/PD-L1 modulation in cancer therapy
$488,332Drew M. Pardoll · Johns Hopkins University · R01 · FY2017 · CA
PD-1/PD-L1 modulation in cancer therapy
$488,332Drew M. Pardoll · Johns Hopkins University · R01 · FY2016 · CA
PD-1/PD-L1 modulation in cancer therapy
$488,332Drew M. Pardoll · Johns Hopkins University · R01 · FY2018 · CA
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
$488,230Harvard University (Medical School) · R01 · FY2000 · CA
Systems Biology of Antigen and T-Cell Transport in Cancer Immunotherapy
$488,228Timothy P Padera · Massachusetts General Hospital · R01 · FY2025 · CA
Immunological Monitoring & Cellular Products
$488,223Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P50 · FY2009 · CA
NHGRI/DIR Zebrafish Core
$488,186David M. Bodine · National Human Genome Research Institute · Z01 · FY2008 · HG
Development of novel AAV vaccine strategy in a pre-clinical model of oral melanoma.
$488,155George V Aslanidi · University Of Minnesota · R01 · FY2025 · CA
Tumor Microenvironment in Cancer Progression
$488,066Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Community Outreach and Engagement
$488,035Carmen E Guerra · University Of Pennsylvania · P30 · FY2023 · CA
Molecular Mechanism and Therapy for Ocular Melanoma
$488,005Joan Heller Brown · University Of California, San Diego · R01 · FY2021 · CA
Molecular Mechanism and Therapy for Ocular Melanoma
$488,005Kang Zhang · University Of California, San Diego · R01 · FY2017 · CA
Molecular Mechanism and Therapy for Ocular Melanoma
$488,005Kang Zhang · University Of California, San Diego · R01 · FY2018 · CA
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
$487,929Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Molecular Basis of Parvoviral Target Cell Specificity
$487,919Peter Tattersall · Yale University · R01 · FY2012 · CA
Defining the role of NF1 and SPRED1 loss in melanoma
$487,530Iwei Yeh · University Of California, San Francisco · R37 · FY2023 · CA
Development of a fast scanning, extended field-of-view multiphoton microscope for clinical skin imaging
$487,499Mihaela Balu · University Of California-Irvine · R01 · FY2019 · EB